Panelists from previous talks returned to field questions on identifying and regulating impairing cannabinoids, goals much more difficult to reach for cannabis than for alcohol.
WSLCB staff planned to renew public dialogue about impairing versus non-impairing cannabinoids, providing an opportunity to question how helpful that dichotomy actually is.
A last-minute hearing on a repackaged bill to regulate synthesized cannabinoids revealed shared public health concerns but testimony otherwise remained just as sharply divided.
Two visions for the future of cannabinoid regulation were presented to senators, with testimony split between a measure developed by WACA members and WSLCB request legislation.
Sharply divided testimony on a bill to add more members and non-voting legislators to the WSLCB board suggested the idea was controversial in both the cannabis and alcohol sectors.
Some licensees, WSLCB staff, and prevention advocates encouraged lawmakers to pass request legislation on cannabinoid regulation, while other licensees preferred a competing bill.
A cannabis researcher from WSU went over academic developments around safety, economic development, health, and agriculture before answering attendee questions.
A panel of experts discussed the chemistry of the cannabis plant and its pharmacology with a focus on the conversion of CBD into other cannabinoids for commercial products.
This week would include interesting events covering a broad spectrum of cannabis-related topics including social equity, behavioral health, delta-8-THC, and substance use prevention.
WSDA staff described program operations, announced allowance of “dietary ingredients,” previewed a web portal, and created a new work group to help expand MIE product types.